Antidepressant treatment outcomes in family medicine.
Autor: | Prasko S; Family Medicine Teaching Centre, Primary Health Care Zenica, Bosnia and Herzegovina., Pranjić N; Department of Occupational Medicine, School of Medicine, University of Tuzla, Bosnia and Herzegovina., Gavran L; Family Medicine Teaching Centre, Primary Health Care Zenica, Bosnia and Herzegovina., Alić A; Family Medicine Teaching Centre, Primary Health Care Zenica, Bosnia and Herzegovina., Gledo I; Family Medicine Teaching Centre, Primary Health Care Zenica, Bosnia and Herzegovina., Ramić E; Department of Family Medicine, Primary Health Care Centre and Polyclinic 'Dr Mustafa Šehovic', Tuzla, Bosnia and Herzegovina., Spahić E; Department of Forensic Medicine, School of Medicine, University of Sarajevo, Bosnia and Herzegovina., Prasko E; Family Medicine Teaching Centre, Primary Health Care Zenica, Bosnia and Herzegovina., Ramić I; Specialized Hospital Heart Centre, Sarajevo, Bosnia and Herzegovina. |
---|---|
Jazyk: | angličtina |
Zdroj: | Medicinski glasnik : official publication of the Medical Association of Zenica-Doboj Canton, Bosnia and Herzegovina [Med Glas (Zenica)] 2019 Aug 01; Vol. 16 (2). Date of Electronic Publication: 2019 Aug 01. |
DOI: | 10.17392/1025-19 |
Abstrakt: | Aim To determine the prevalence of depressive episodes and recurrent depressive disorders despite of the length of therapy and type of antidepressants. Methods The study was conducted among 508 patients aged 19-65 years who were treated for depression for at least 3 months (mild and moderate episodes were controlled and the effects of treatment monitored by family physicians, while severe episodes were controlled by a psychiatrist) during 2013- 2015 in Zenica-Doboj Canton using the Hamilton Depression Rating Scale (HDRS). Results The average age of the patients was 48.98±11.585 years. Depressive disorder was most commonly represented in patients with high-level education, 22%, more frequently in non-productive workers (non-productive vs. manufacturing 58%:35%). A significant number of patients who were treated for depression were unemployed (57%). All respondents were suffering from the most serious episode of depression with an average depression rate at the Hamilton scale 18.49±8.603, with a very serious depression level of 32%, severe 17%, moderate 21%, and mild 20%. Most patients were treated with paroxetine, 27%, fluoxetine 22% and sertraline 17%. Efficacy of depression treatment with different types of selective serotonin reuptake inhibitors antidepressants (SSRIs) was not significantly different (p=0.502). Conclusion Success of the treatment with the absence of symptoms of depression was achieved in 10% and the maintenance of depressive episodes occurred in 90% of cases. Adverse reactions with the most commonly prescribed SSRI in our country should be important in creating procedures and strategies for the future treatment of depression in family medicine. (Copyright© by the Medical Assotiation of Zenica-Doboj Canton.) |
Databáze: | MEDLINE |
Externí odkaz: |